Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Koff

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|December 1, 1992
The low efficiency of maternal-neonatal transmission of hepatitis C virus: how certain are we?R S Koff
International Journal for Parasitology|June 5, 2003
Hepatitis vaccines: recent advancesRaymond S Koff
Seminars in Liver Disease|February 1, 1981
Management of the hepatitis B surface antigen (HBsAg) carrierR S Koff
JAMA|February 8, 1995
Herbal hepatotoxicity. Revisiting a dangerous alternativeR S Koff
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|January 1, 1972
Acute toxic effects of D-galactosamine on human embryo liver cells in tissue cultureR S Koff
The American Journal of Gastroenterology|October 1, 1996
Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimenR S Koff
Gastroenterology|October 1, 1989
Non-A, non-B hepatitis: finally the big breakthroughR S Koff
Gastroenterology|July 30, 2015
Cirrhosis: A Practical Guide to ManagementRaymond S Koff
Hospital Practice (Office Ed.)|November 15, 1987
Fulminant hepatitis due to HBV/HDV coinfectionR S Koff
Hepatology (Baltimore, Md.)|September 26, 1997
Therapy of hepatitis C: cost-effectiveness analysisR S Koff
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|December 1, 1992
The low efficiency of maternal-neonatal transmission of hepatitis C virus: how certain are we?R S Koff
International Journal for Parasitology|June 5, 2003
Hepatitis vaccines: recent advancesRaymond S Koff
Seminars in Liver Disease|February 1, 1981
Management of the hepatitis B surface antigen (HBsAg) carrierR S Koff
JAMA|February 8, 1995
Herbal hepatotoxicity. Revisiting a dangerous alternativeR S Koff
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|January 1, 1972
Acute toxic effects of D-galactosamine on human embryo liver cells in tissue cultureR S Koff
The American Journal of Gastroenterology|October 1, 1996
Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimenR S Koff
Gastroenterology|October 1, 1989
Non-A, non-B hepatitis: finally the big breakthroughR S Koff
Gastroenterology|July 30, 2015
Cirrhosis: A Practical Guide to ManagementRaymond S Koff
Hospital Practice (Office Ed.)|November 15, 1987
Fulminant hepatitis due to HBV/HDV coinfectionR S Koff
Hepatology (Baltimore, Md.)|September 26, 1997
Therapy of hepatitis C: cost-effectiveness analysisR S Koff
Pageof 18